New drug brief application for injection line mycobacteria D in Haizheng Pharmaceuticals obtains FDA review approval
-
Last Update: 2020-06-09
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
Today, Haizheng Pharmaceuticals announced that thenew drug(http://application (andA,
or http://for injection line iurethane D declared by the holding sub-
company(http://Haizheng Pharmaceutical co..Spharmaceutical company (http:// and theof the u.S.
FDA (http://About injection with lineme D
injection line mycobacterium D as anti-tumordrug (http:// , the efficacy of Hodgkin's disease and neuroblastoma is prominent, especially to control fever ; , similar to the effect of single MTX, is also effective for testicular cancer, generally in combination with other drug (http:// , combined with radiotherapy to treat childhood renal mukoma (Wilms) can improve survival rate, also effective for Ewing sarcoma and cross-line muscle tumors The original research drug Cosmegen for Injection USP, 0.5 mg/vial was developed by Recordati RareDiseases Inc., and currently produced and sold domestically and internationally, mainly MERCK SHARP DOHME, MYLAN INSTITUTION, Hanjun Pharmaceutical Co., Ltd., Shanghai Pharmaceutical Sinapharmaceutical Co., Ltd Up to now, Haizheng Pharmaceuticals has invested about RMB 712.15 million in the research and development project of injection line mycobacteria D
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
